216 related articles for article (PubMed ID: 24838146)
1. Eosinophils and mast cells in leishmaniasis.
Rodríguez NE; Wilson ME
Immunol Res; 2014 Aug; 59(1-3):129-41. PubMed ID: 24838146
[TBL] [Abstract][Full Text] [Related]
2. Using meta-analysis and machine learning to investigate the transcriptional response of immune cells to Leishmania infection.
Rezaei Z; Tahmasebi A; Pourabbas B
PLoS Negl Trop Dis; 2024 Jan; 18(1):e0011892. PubMed ID: 38190401
[TBL] [Abstract][Full Text] [Related]
3. Macrophages and neutrophils cooperate in immune responses to Leishmania infection.
Filardy AA; Pires DR; DosReis GA
Cell Mol Life Sci; 2011 Jun; 68(11):1863-70. PubMed ID: 21369708
[TBL] [Abstract][Full Text] [Related]
4. Leishmania and the macrophage: a multifaceted interaction.
Podinovskaia M; Descoteaux A
Future Microbiol; 2015; 10(1):111-29. PubMed ID: 25598341
[TBL] [Abstract][Full Text] [Related]
5. Exposure to Leishmania braziliensis triggers neutrophil activation and apoptosis.
Falcão SA; Weinkopff T; Hurrell BP; Celes FS; Curvelo RP; Prates DB; Barral A; Borges VM; Tacchini-Cottier F; de Oliveira CI
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003601. PubMed ID: 25756874
[TBL] [Abstract][Full Text] [Related]
6. NLR proteins and parasitic disease.
Clay GM; Sutterwala FS; Wilson ME
Immunol Res; 2014 Aug; 59(1-3):142-52. PubMed ID: 24989828
[TBL] [Abstract][Full Text] [Related]
7. Role of galectin-3 in the initial control of Leishmania infection.
Sato S; Bhaumik P; St-Pierre G; Pelletier I
Crit Rev Immunol; 2014; 34(2):147-75. PubMed ID: 24940913
[TBL] [Abstract][Full Text] [Related]
8. Host Mast Cells in Leishmaniasis: Friend or Foe?
Naqvi N; Srivastava R; Selvapandiyan A; Puri N
Trends Parasitol; 2020 Dec; 36(12):952-956. PubMed ID: 33060062
[TBL] [Abstract][Full Text] [Related]
9. The Roles of Mast Cells in Parasitic Protozoan Infections.
Lu F; Huang S
Front Immunol; 2017; 8():363. PubMed ID: 28428784
[TBL] [Abstract][Full Text] [Related]
10. Evidence for direct interaction between mast cells and Leishmania parasites.
Bidri M; Vouldoukis I; Mossalayi MD; Debré P; Guillosson JJ; Mazier D; Arock M
Parasite Immunol; 1997 Oct; 19(10):475-83. PubMed ID: 9372516
[TBL] [Abstract][Full Text] [Related]
11. Th17 Cell and Inflammatory Infiltrate Interactions in Cutaneous Leishmaniasis: Unraveling Immunopathogenic Mechanisms.
Morales-Primo AU; Becker I; Pedraza-Zamora CP; Zamora-Chimal J
Immune Netw; 2024 Apr; 24(2):e14. PubMed ID: 38725676
[TBL] [Abstract][Full Text] [Related]
12. Eosinophils of patients with localized and diffuse cutaneous leishmaniasis: Differential response to Leishmania mexicana, with insights into mechanisms of damage inflicted upon the parasites by eosinophils.
Salaiza-Suazo N; Porcel-Aranibar R; Cañeda-Guzmán IC; Ruiz-Remigio A; Zamora-Chimal J; Delgado-Domínguez J; Cervantes-Sarabia R; Carrada-Figueroa G; Sánchez-Barragán B; Leal-Ascencio VJ; Pérez-Torres A; Rodríguez-Martínez HA; Becker I
PLoS One; 2024; 19(2):e0296887. PubMed ID: 38359037
[TBL] [Abstract][Full Text] [Related]
13. Unrevealing the Mystery of Latent Leishmaniasis: What Cells Can Host
Valigurová A; Kolářová I
Pathogens; 2023 Feb; 12(2):. PubMed ID: 36839518
[No Abstract] [Full Text] [Related]
14. Essential Role of Enzymatic Activity in the Leishmanicidal Mechanism of the Eosinophil Cationic Protein (RNase 3).
Abengózar MÁ; Fernández-Reyes M; Salazar VA; Torrent M; de la Torre BG; Andreu D; Boix E; Rivas L
ACS Infect Dis; 2022 Jul; 8(7):1207-1217. PubMed ID: 35731709
[TBL] [Abstract][Full Text] [Related]
15. Insight Into the Long Noncoding RNA and mRNA Coexpression Profile in the Human Blood Transcriptome Upon
Maruyama SR; Fuzo CA; Oliveira AER; Rogerio LA; Takamiya NT; Pessenda G; de Melo EV; da Silva AM; Jesus AR; Carregaro V; Nakaya HI; Almeida RP; da Silva JS
Front Immunol; 2022; 13():784463. PubMed ID: 35370994
[TBL] [Abstract][Full Text] [Related]
16. Hide-and-Seek: A Game Played between Parasitic Protists and Their Hosts.
Kolářová I; Valigurová A
Microorganisms; 2021 Nov; 9(12):. PubMed ID: 34946036
[TBL] [Abstract][Full Text] [Related]
17. Epidemiologic, Clinical and Immunological Consequences of Co-Infections during Canine Leishmaniosis.
Beasley EA; Pessôa-Pereira D; Scorza BM; Petersen CA
Animals (Basel); 2021 Nov; 11(11):. PubMed ID: 34827938
[TBL] [Abstract][Full Text] [Related]
18. Amentoflavone as an Ally in the Treatment of Cutaneous Leishmaniasis: Analysis of Its Antioxidant/Prooxidant Mechanisms.
Rizk YS; Santos-Pereira S; Gervazoni L; Hardoim DJ; Cardoso FO; de Souza CDSF; Pelajo-Machado M; Carollo CA; de Arruda CCP; Almeida-Amaral EE; Zaverucha-do-Valle T; Calabrese KDS
Front Cell Infect Microbiol; 2021; 11():615814. PubMed ID: 33718267
[TBL] [Abstract][Full Text] [Related]
19. Clinical and immunological characteristics of tegumentary leishmaniasis cases in Bolivia.
Ballart C; Torrico MC; Vidal G; Torrico F; Lozano D; Gállego M; Pinto L; Rojas E; Aguilar R; Dobaño C; Ares-Gomez S; Picado A
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009223. PubMed ID: 33667232
[TBL] [Abstract][Full Text] [Related]
20. The Effects of Silver Nanoparticles Biosynthesized Using Fig and Olive Extracts on Cutaneous leishmaniasis Induced Inflammation in Female Balb/c Mice.
Almayouf MA; El-Khadragy MF; Awad MA; Al-Olayan EM
Biosci Rep; 2020 Nov; 40(12):. PubMed ID: 33252120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
